Back to Diagnostics & Biomarkers
Diagnostics & Biomarkers

Continuous Glucose MonitorEvidence & Dosage

Echtzeit-Blutzucker via Sensor — Lernkurve und Limitationen.

Studies last updated

Evidence at a glance

Total studies
1,000
With abstract
48
Meta / Systematic / RCT
158
Highly cited
50
Publication years
2001–2026

Continuous Glucose Monitor in the context of Diagnostics & Biomarkers

This topic is part of our "Diagnostics & Biomarkers" world. There you'll find methodology, evidence and the highest-impact levers — plus the order in which they sensibly build on each other.

Go to Diagnostics & Biomarkers

Top studies on Continuous Glucose Monitor

Ranked by influential-citation count (Semantic Scholar) and publication year.

  1. Continuous glucose monitoring in adults with type 2 diabetes: a systematic review and meta-analysis.

    Diabetologia2024Meta-Analysis200 influential citations

    <h4>Aims/hypothesis</h4>Continuous glucose monitoring (CGM) is increasingly used in the treatment of type 2 diabetes, but the effects on glycaemic control are unclear. The aim of this systematic review and meta-analysis is to provide a…

  2. Efficacy and Safety of Continuous Glucose Monitoring and Intermittently Scanned Continuous Glucose Monitoring in Patients With Type 2 Diabetes: A Systematic Review and Meta-analysis of Interventional Evidence.

    Diabetes Care2024Meta-Analysis187 influential citations

    <h4>Background</h4>Traditional diabetes self-monitoring of blood glucose (SMBG) involves inconvenient finger pricks. Continuous glucose monitoring (CGM) and intermittently scanned CGM (isCGM) systems offer CGM, enhancing type 2 diabetes…

  3. Effects of Continuous Glucose Monitoring on Metrics of Glycemic Control in Diabetes: A Systematic Review With Meta-analysis of Randomized Controlled Trials.

    Diabetes Care2020Meta-Analysis171 influential citations

    BACKGROUND Continuous glucose monitoring (CGM) provides important information to aid in achieving glycemic targets in people with diabetes. PURPOSE We performed a meta-analysis of randomized controlled trials (RCTs) comparing CGM with…

  4. Effect of artificial pancreas systems on glycaemic control in patients with type 1 diabetes: a systematic review and meta-analysis of outpatient randomised controlled trials.

    Lancet Diabetes Endocrinol2017n=585Meta-Analysis162 influential citations

    <h4>Background</h4>Closed-loop artificial pancreas systems have been in development for several years, including assessment in numerous varied outpatient clinical trials. We aimed to summarise the efficacy and safety of artificial pancreas…

  5. Continuous Glucose Monitoring Systems in Noninsulin-Treated People with Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

    Diabetes Technol Ther2024Meta-Analysis126 influential citations

    <b><i>Introduction:</i></b> Continuous glucose monitoring (CGM) has shown favorable outcomes in patients with type 2 diabetes (T2D) who are on insulin therapy. However, the efficacy of CGM in managing glucose levels in noninsulin-treated…

  6. Comparative effectiveness and safety of methods of insulin delivery and glucose monitoring for diabetes mellitus: a systematic review and meta-analysis.

    Ann Intern Med2012n=33Meta-Analysis119 influential citations

    <h4>Background</h4>Patients with diabetes mellitus need information about the effectiveness of innovations in insulin delivery and glucose monitoring.<h4>Purpose</h4>To review how intensive insulin therapy (multiple daily injections [MDI]…

  7. Effectiveness of Continuous Glucose Monitoring on Metrics of Glycemic Control in Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis of Randomized Controlled Trials.

    J Clin Endocrinol Metab2024n=14meta115 influential citations

    PURPOSE: To provide a systematic review and meta-analysis synthesizing the findings of randomized controlled trials (RCTs) of continuous glucose monitors (CGMs) in the management of adults with type 2 diabetes mellitus (T2DM) on glucose…

  8. Effectiveness of continuous glucose monitoring in maintaining glycaemic control among people with type 1 diabetes mellitus: a systematic review of randomised controlled trials and meta-analysis.

    Diabetologia2022Meta-Analysis112 influential citations

    <h4>Aims/hypothesis</h4>The aim of this work was to assess the effectiveness of continuous glucose monitoring (CGM) vs self-monitoring of blood glucose (SMBG) in maintaining glycaemic control among people with type 1 diabetes…

  9. Use of continuous glucose monitoring and point-of-care glucose testing in hospitalized patients with diabetes mellitus in non-intensive care unit settings: A systematic review and meta-analysis of randomized controlled trials.

    Diabetes Res Clin Pract2025n=979Meta-Analysis87 influential citations

    The benefits of using continuous glucose monitoring (CGM) in hospitalized patients with diabetes remain uncertain. Point-of-care (POC) glucose testing is the standard of care in this setting. We compared the effect of adding CGM to POC…

  10. Efficacy of continuous glucose monitoring on maternal and neonatal outcomes in gestational diabetes mellitus: a systematic review and meta-analysis of randomized clinical trials.

    Diabet Med2022Meta-Analysis77 influential citations

    Aims This systematic review aims to evaluate the effect of continuous glucose monitoring (CGM) on maternal and neonatal outcomes in gestational diabetes mellitus (GDM). Methods Two authors conducted a systematic search using PubMed,…

Frequently asked

Are there safety considerations for Continuous Glucose Monitor?
• Few studies reported adverse events. • Few studies reported emergency department use or hospitalization.

Related articles

More topics in Diagnostics & Biomarkers

Blood Glucose

Nüchtern, postprandial, Glukoseschwankungen — Grundlage für metabolische Gesundheit.

Blood Pressure Tracking

Häusliche Messung, 24h-Messung, Weißkittelhypertonie.

Body Temperature Tracking

Basaltemperatur, Zyklus, Krankheit, Schlafphasen via Wearable.

Complete Blood Count

Kleines/großes Blutbild, Erythrozyten, Leukozyten, Thrombozyten — Standardpanel.

Cycle Tracking

Menstruationszyklus, Symptome, Fertilität — Apps und Wearables.

Fasting Insulin & HOMA-IR

Insulinresistenz früh erkennen — wichtiger als HbA1c bei Risiko-Patienten.

Geroscience Biomarkers

Automatisch via Trend Scout entdeckt. Aging biomarkers and biological clocks are central to longevity interventions and geroscience research.. PubMed: 479 Ergebnisse.

HbA1c

3-Monats-Mittel des Blutzuckers, diabetisches Risiko, Longevity-Marker.

Homocysteine

Methylierungs-Marker, kardiovaskuläres und neurologisches Risiko.

HRV Tracking

Herzratenvariabilität als Resilienz- und Erholungs-Indikator.

Inflammation Markers

hs-CRP, IL-6, Fibrinogen — chronische niedriggradige Entzündung als Risikofaktor.

Kidney Values

Kreatinin, Harnstoff, eGFR, Cystatin C — Nierenfunktion bewerten.

Lipid Profile

LDL-C, HDL, Triglyceride, ApoB — moderne kardiovaskuläre Risiko-Bewertung.

Liver Values

ALT, AST, GGT, Bilirubin — was hohe Werte bedeuten und wann sie ein Problem sind.

Mood Tracking

Daily Mood Logging, Korrelationen mit Schlaf/Bewegung/Ernährung.

Nutrition Tracking

Cronometer, MyFitnessPal, Makros & Mikros, Limitationen.

Resting Heart Rate

Trend-Marker für kardiovaskuläre Fitness und Übertraining.

Thyroid Panel

TSH, fT3, fT4, ggf. reverse T3 und Antikörper — vollständiges Schilddrüsen-Panel.

VO2max

Maximale Sauerstoffaufnahme — stärkster Longevity-Prädiktor.

Wearables

Übersicht: Oura, Whoop, Apple Watch, Garmin, Fitbit — Vor- und Nachteile.

Related topics from other worlds